Cell Line : OCI-LY10
Cellosaurus Index : CVCL_8795
Cellosaurus ID : OCI-LY10
CTRP1 Name
, CTRP2 Name
: OCILY10
CCLE Name
: OCILY10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
Cancer Type : haematopoietic_and_lymphoid_tissue
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| OCI-LY10 | (-)-gallocatechin-3-monogallate | CTRP1 | 2.3125 | 296.0000 |
|
| OCI-LY10 | 16-beta-bromoandrosterone | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| OCI-LY10 | 16,16-dimethylprostaglandin-E2 | CTRP1 | 0.1302 | 33.3330 |
|
| OCI-LY10 | 1S,3R-RSL-3 | CTRP2,CTRP1 | 0.0010 | 17.0000 |
|
| OCI-LY10 | 2-bromopyruvate | CTRP1 | 4.1667 | 533.3300 |
|
| OCI-LY10 | 2-fluoropalmitic acid | CTRP1 | 0.5781 | 148.0000 |
|
| OCI-LY10 | 2,4-dideoxy-DC-45-A2 | CTRP1 | 0.0163 | 2.0833 |
|
| OCI-LY10 | 3-chloro-L-alanine | CTRP1 | 0.0163 | 2.0833 |
|
| OCI-LY10 | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | 4-IPP | CTRP1 | 1.0417 | 133.3300 |
|
| OCI-LY10 | 4-methylfasudil | CTRP1 | 1.0417 | 133.3300 |
|
| OCI-LY10 | 6-diazo-5-oxo-L-norleucine | CTRP1 | 1.0417 | 133.3300 |
|
| OCI-LY10 | 7-nitroindazole | CTRP1 | 2.0833 | 266.6700 |
|
| OCI-LY10 | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | AA-COCF3 | CTRP2,CTRP1 | 0.0010 | 266.6700 |
|
| OCI-LY10 | ABT-751 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | ABT737 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| OCI-LY10 | AC55649 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | AEW541 | CCLE | 0.0025 | 8.0000 |
|
| OCI-LY10 | Afatinib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | AGK-2 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | Alda-1 | CTRP1 | 1.0417 | 133.3300 |
|
| OCI-LY10 | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| OCI-LY10 | Alpelisib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | AM-580 | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| OCI-LY10 | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | ASN 05257430 | CTRP1 | 0.1445 | 37.0000 |
|
| OCI-LY10 | AT-406 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | austocystin D | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| OCI-LY10 | avicin D | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | avrainvillamide | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | AZD-7545 | CTRP2,CTRP1 | 0.0023 | 74.0000 |
|
| OCI-LY10 | AZD1480 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | AZD4547 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | AZD8055 | CTRP2 | 0.0020 | 33.0000 |
|
| OCI-LY10 | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| OCI-LY10 | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | batimastat | CTRP1 | 1.1562 | 148.0000 |
|
| OCI-LY10 | Bax channel blocker | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BEC | CTRP1 | 2.0833 | 266.6700 |
|
| OCI-LY10 | Belinostat | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BI-2536 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | BIBR-1532 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| OCI-LY10 | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BIX-01294 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | blebbistatin | CTRP1 | 1.0417 | 133.3300 |
|
| OCI-LY10 | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BML-259 | CTRP1 | 2.0833 | 266.6700 |
|
| OCI-LY10 | BMS-191011 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BMS-299897 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | BMS-345541 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BMS-536924 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| OCI-LY10 | BMS-641988 | CTRP1 | 0.2891 | 37.0000 |
|
| OCI-LY10 | BMS-754807 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | Bortezomib | CTRP1 | 0.0010 | 0.1300 |
|
| OCI-LY10 | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| OCI-LY10 | BRD-A05715709 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | BRD-A86708339 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K03536150 | CTRP2 | 0.0081 | 270.0000 |
|
| OCI-LY10 | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| OCI-LY10 | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K34222889 | CTRP2 | 0.0017 | 57.0000 |
|
| OCI-LY10 | BRD-K35604418 | CTRP2 | 0.0081 | 270.0000 |
|
| OCI-LY10 | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K42260513 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K48477130 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K50799972 | CTRP2 | 0.0020 | 17.0000 |
|
| OCI-LY10 | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K51831558 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K55116708 | CTRP2 | 0.0020 | 17.0000 |
|
| OCI-LY10 | BRD-K55473186 | CTRP2 | 0.0020 | 33.0000 |
|
| OCI-LY10 | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| OCI-LY10 | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K90370028 | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| OCI-LY10 | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD0713 | CTRP1 | 0.6250 | 80.0000 |
|
| OCI-LY10 | BRD1812 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| OCI-LY10 | BRD2572 | CTRP1 | 0.3125 | 80.0000 |
|
| OCI-LY10 | BRD2762 | CTRP1 | 0.6250 | 80.0000 |
|
| OCI-LY10 | BRD4046 | CTRP1 | 0.6250 | 80.0000 |
|
| OCI-LY10 | BRD4132 | CTRP2 | 0.0049 | 80.0000 |
|
| OCI-LY10 | BRD4372 | CTRP1 | 0.6250 | 80.0000 |
|
| OCI-LY10 | BRD4770 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | BRD55319 | CTRP1 | 0.2891 | 37.0000 |
|
| OCI-LY10 | BRD5802 | CTRP1 | 0.6250 | 80.0000 |
|
| OCI-LY10 | BRD6150 | CTRP1 | 0.3125 | 80.0000 |
|
| OCI-LY10 | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | BRD63610 | CTRP1 | 0.0081 | 1.0417 |
|
| OCI-LY10 | BRD6368 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | BRD6825 | CTRP1 | 0.6250 | 80.0000 |
|
| OCI-LY10 | BRD7137 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | BRD8097 | CTRP1 | 0.6250 | 80.0000 |
|
| OCI-LY10 | BRD8418 | CTRP1 | 0.6250 | 80.0000 |
|
| OCI-LY10 | BRD8899 | CTRP2 | 0.0020 | 33.0000 |
|
| OCI-LY10 | BRD8958 | CTRP2,CTRP1 | 0.0020 | 66.6670 |
|
| OCI-LY10 | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | BRD9658 | CTRP1 | 0.6250 | 80.0000 |
|
| OCI-LY10 | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| OCI-LY10 | brefeldin A | CTRP1 | 0.0023 | 0.2890 |
|
| OCI-LY10 | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | BX795 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | canertinib | CTRP2 | 0.0020 | 33.0000 |
|
| OCI-LY10 | capsaicin | CTRP1 | 4.1667 | 533.3300 |
|
| OCI-LY10 | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| OCI-LY10 | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| OCI-LY10 | CAY10594 | CTRP2,CTRP1 | 0.0020 | 533.3300 |
|
| OCI-LY10 | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | CBB-1007 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | CCT036477 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | CD-1530 | CTRP1 | 1.0417 | 133.3300 |
|
| OCI-LY10 | CD-437 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| OCI-LY10 | Cediranib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | cerulenin | CTRP2,CTRP1 | 0.0045 | 150.0000 |
|
| OCI-LY10 | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | chaetocin | CTRP1 | 0.0020 | 0.2600 |
|
| OCI-LY10 | CHEMBL1222381 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| OCI-LY10 | CHEMBL374350 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | CHEMBL399379 | CTRP1 | 2.0833 | 266.6700 |
|
| OCI-LY10 | CHIR-99021 | CTRP2,CTRP1 | 0.0024 | 80.0000 |
|
| OCI-LY10 | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| OCI-LY10 | CHM-1 | CTRP2,CTRP1 | 0.0005 | 16.0000 |
|
| OCI-LY10 | CI-976 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| OCI-LY10 | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | ciclosporin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | CID 2853753 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | CIL41 | CTRP1 | 1.2500 | 160.0000 |
|
| OCI-LY10 | CIL55 | CTRP1 | 1.2500 | 160.0000 |
|
| OCI-LY10 | CIL55A | CTRP1 | 0.6250 | 80.0000 |
|
| OCI-LY10 | CIL56 | CTRP1 | 0.3125 | 40.0000 |
|
| OCI-LY10 | CIL70 | CTRP1 | 0.1562 | 40.0000 |
|
| OCI-LY10 | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | COL-3 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Compound 10b | CTRP1 | 1.1562 | 148.0000 |
|
| OCI-LY10 | Compound 110 | CTRP1 | 0.5781 | 74.0000 |
|
| OCI-LY10 | Compound 12 | CTRP1 | 0.2891 | 37.0000 |
|
| OCI-LY10 | Compound 1541A | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| OCI-LY10 | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Compound 23 citrate | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | Compound 4 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | Compound 44 | CTRP1 | 1.0417 | 133.3300 |
|
| OCI-LY10 | Compound 7d-cis | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | CR-1-31B | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | Crizotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| OCI-LY10 | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| OCI-LY10 | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| OCI-LY10 | cyanoquinoline 11 | CTRP1 | 1.0417 | 133.3300 |
|
| OCI-LY10 | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | cytochalasin B | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | cytosporone B | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | Dabrafenib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Dactolisib | CTRP2,CTRP1 | 0.0005 | 17.0000 |
|
| OCI-LY10 | dalcetrapib | CTRP1 | 2.0687 | 264.8000 |
|
| OCI-LY10 | Daporinad | CTRP2,CTRP1 | 0.0001 | 2.0000 |
|
| OCI-LY10 | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | DC-45-A2 | CTRP1 | 0.2891 | 37.0000 |
|
| OCI-LY10 | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| OCI-LY10 | dexamethasone | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | DG-041 | CTRP1 | 0.5208 | 133.3300 |
|
| OCI-LY10 | Dinaciclib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | DL-TBOA | CTRP1 | 4.1667 | 533.3300 |
|
| OCI-LY10 | Docetaxel | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| OCI-LY10 | Doramapimod | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| OCI-LY10 | ELCPK | CTRP1 | 0.0031 | 0.4000 |
|
| OCI-LY10 | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | endo-IWR-1 | CTRP1 | 0.1302 | 33.3330 |
|
| OCI-LY10 | Entinostat | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| OCI-LY10 | erastin | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| OCI-LY10 | erastin-A8 | CTRP1 | 0.1250 | 16.0000 |
|
| OCI-LY10 | Erlotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| OCI-LY10 | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| OCI-LY10 | etomoxir | CTRP2,CTRP1 | 0.0090 | 300.0000 |
|
| OCI-LY10 | Etoposide | CTRP2,CTRP1 | 0.0009 | 28.3180 |
|
| OCI-LY10 | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | fatostatin | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | Fedratinib | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| OCI-LY10 | FGIN-1-27 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | fluoropyruvate | CTRP1 | 1.1562 | 148.0000 |
|
| OCI-LY10 | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| OCI-LY10 | Flutamide | CTRP1 | 0.7542 | 96.5330 |
|
| OCI-LY10 | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | FQI-1 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | FQI-2 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | fumagillol | CTRP1 | 4.1667 | 533.3300 |
|
| OCI-LY10 | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| OCI-LY10 | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Gefitinib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Gemcitabine | CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| OCI-LY10 | glibenclamide | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | Gly-Gly-PALO | CTRP1 | 2.0833 | 266.6700 |
|
| OCI-LY10 | GMX-1778 | CTRP2,CTRP1 | 0.0000 | 0.3000 |
|
| OCI-LY10 | gossypol | CTRP1 | 0.2891 | 37.0000 |
|
| OCI-LY10 | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | GSK1059615 | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | GW-405833 | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| OCI-LY10 | GW843682X | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | HLI 373 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Ibrutinib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | idarubicin | CTRP1 | 0.0020 | 0.2600 |
|
| OCI-LY10 | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| OCI-LY10 | indisulam | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | isoevodiamine | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | isoliquiritigenin | CTRP1 | 0.1302 | 33.3330 |
|
| OCI-LY10 | isonicotinohydroxamic acid | CTRP2 | 0.0010 | 17.0000 |
|
| OCI-LY10 | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 8.3000 |
|
| OCI-LY10 | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | itraconazole | CTRP2,CTRP1 | 0.0005 | 33.3330 |
|
| OCI-LY10 | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| OCI-LY10 | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| OCI-LY10 | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| OCI-LY10 | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | JW-74 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | JZL-184 | CTRP1 | 0.2891 | 37.0000 |
|
| OCI-LY10 | kahalalide F | CTRP1 | 0.1302 | 33.3330 |
|
| OCI-LY10 | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | kinetin riboside | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | Ko-143 | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| OCI-LY10 | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | KU-55933 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | L-685458 | CTRP2,CCLE | 0.0011 | 37.0000 |
|
| OCI-LY10 | Lapatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| OCI-LY10 | LBW242 | CCLE | 0.0025 | 8.0000 |
|
| OCI-LY10 | LDN-193189 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | LE-135 | CTRP2,CTRP1 | 0.0020 | 66.6670 |
|
| OCI-LY10 | Lenalidomide | CTRP1 | 4.6250 | 592.0000 |
|
| OCI-LY10 | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | leucascandrolide A | CTRP1 | 0.0163 | 2.0833 |
|
| OCI-LY10 | LFM-A13 | CTRP1 | 2.8935 | 370.3700 |
|
| OCI-LY10 | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Linsitinib | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | lonidamine | CTRP1 | 4.6250 | 592.0000 |
|
| OCI-LY10 | losartan | CTRP1 | 4.1667 | 533.3300 |
|
| OCI-LY10 | lovastatin acid | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| OCI-LY10 | LRRK2-IN-1 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | LY-2183240 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | m-3M3-FBS | CTRP1 | 2.0833 | 266.6700 |
|
| OCI-LY10 | manumycin A | CTRP2,CTRP1 | 0.0009 | 30.2680 |
|
| OCI-LY10 | maraviroc | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | marinopyrrole A | CTRP2 | 0.0020 | 33.0000 |
|
| OCI-LY10 | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Merck60 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | Methotrexate | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | methylstat | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | MG-132 | CTRP2 | 0.0006 | 20.0000 |
|
| OCI-LY10 | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | MI-2 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | MIRA-1 | CTRP2 | 0.0020 | 33.0000 |
|
| OCI-LY10 | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| OCI-LY10 | MK-1775 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | MK-591 | CTRP1 | 2.0833 | 266.6700 |
|
| OCI-LY10 | ML006 | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| OCI-LY10 | ML007 | CTRP1 | 0.2891 | 37.0000 |
|
| OCI-LY10 | ML013 | CTRP1 | 0.2604 | 66.6670 |
|
| OCI-LY10 | ML030 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| OCI-LY10 | ML050 | CTRP2,CTRP1 | 0.0020 | 66.6670 |
|
| OCI-LY10 | ML100 | CTRP1 | 0.1302 | 33.3330 |
|
| OCI-LY10 | ML101 | CTRP1 | 2.0833 | 266.6700 |
|
| OCI-LY10 | ML150 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | ML159 | CTRP1 | 1.0417 | 133.3300 |
|
| OCI-LY10 | ML160 | CTRP1 | 1.0417 | 133.3300 |
|
| OCI-LY10 | ML162 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | ML203 | CTRP2,CTRP1 | 0.0011 | 296.0000 |
|
| OCI-LY10 | ML210 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| OCI-LY10 | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| OCI-LY10 | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | myriocin | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | N-oxalyl-D-phenylalanine | CTRP1 | 4.1667 | 533.3300 |
|
| OCI-LY10 | N9-isopropylolomoucine | CTRP2,CTRP1 | 0.0120 | 408.5000 |
|
| OCI-LY10 | nakiterpiosin | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | Navitoclax | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| OCI-LY10 | necrostatin-1 | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| OCI-LY10 | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Nelarabine | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | neopeltolide | CTRP1 | 0.0000 | 1.1533 |
|
| OCI-LY10 | neratinib | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | nifedipine | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | Nilotinib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | NPC-26 | CTRP2,CTRP1 | 0.0012 | 40.0000 |
|
| OCI-LY10 | NSC 74859 | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| OCI-LY10 | NSC23766 | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| OCI-LY10 | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | NSC632839 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | NSC95397 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | Nutlin-3a | CTRP2,CTRP1,CCLE | 0.0025 | 150.0000 |
|
| OCI-LY10 | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | NVP-ADW742 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | NVP-AUY922 | CTRP1 | 0.0001 | 33.3330 |
|
| OCI-LY10 | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | NVP-TAE684 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| OCI-LY10 | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Olaparib | CTRP2,CTRP1 | 0.0045 | 150.0000 |
|
| OCI-LY10 | oligomycin A | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | orteronel | CTRP1 | 0.5208 | 133.3300 |
|
| OCI-LY10 | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | OSW-1 | CTRP1 | 0.0010 | 16.6670 |
|
| OCI-LY10 | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| OCI-LY10 | Oxaliplatin | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | P-0850 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | PAC-1 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | Paclitaxel | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| OCI-LY10 | palmostatin B | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | panduratin A | CTRP1 | 2.0833 | 266.6700 |
|
| OCI-LY10 | Panobinostat | CCLE | 0.0025 | 8.0000 |
|
| OCI-LY10 | parbendazole | CTRP2,CTRP1 | 0.0020 | 66.6670 |
|
| OCI-LY10 | Parthenolide | CTRP2,CTRP1 | 0.0020 | 533.3300 |
|
| OCI-LY10 | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | PD0325901 | CCLE | 0.0025 | 8.0000 |
|
| OCI-LY10 | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | PDMP | CTRP2,CTRP1 | 0.0065 | 213.3300 |
|
| OCI-LY10 | Pemetrexed | CTRP1 | 2.3125 | 296.0000 |
|
| OCI-LY10 | Pevonedistat | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| OCI-LY10 | PF-04217903 | CTRP1 | 1.0417 | 133.3300 |
|
| OCI-LY10 | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | PF-3845 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | PF-750 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| OCI-LY10 | PHA-665752 | CCLE | 0.0025 | 8.0000 |
|
| OCI-LY10 | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | phloretin | CTRP2,CTRP1 | 0.0180 | 592.0000 |
|
| OCI-LY10 | PI-103 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| OCI-LY10 | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | pifithrin-alpha | CTRP2,CTRP1 | 0.0071 | 232.7700 |
|
| OCI-LY10 | pifithrin-mu | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | PIK-75 | CTRP1 | 0.0023 | 0.2890 |
|
| OCI-LY10 | Piperlongumine | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | PK-11195 | CTRP1 | 4.1667 | 533.3300 |
|
| OCI-LY10 | PL-DI | CTRP2 | 0.0020 | 33.0000 |
|
| OCI-LY10 | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | PLX-4720 | CTRP2,CCLE | 0.0010 | 33.0000 |
|
| OCI-LY10 | PNU-74654 | CTRP1 | 2.0833 | 266.6700 |
|
| OCI-LY10 | PP-30 | CTRP1 | 0.2891 | 37.0000 |
|
| OCI-LY10 | PRIMA-1 | CTRP1 | 1.1562 | 148.0000 |
|
| OCI-LY10 | PRIMA-1MET | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | PRL-3 Inhibitor I | CTRP1 | 1.0417 | 133.3300 |
|
| OCI-LY10 | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | PT-630 | CTRP1 | 0.1302 | 33.3330 |
|
| OCI-LY10 | purmorphamine | CTRP1 | 1.1562 | 148.0000 |
|
| OCI-LY10 | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | pyrvinium pamoate | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | QS11 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | quinoclamine | CTRP1 | 0.2891 | 37.0000 |
|
| OCI-LY10 | Quizartinib | CTRP2 | 0.0020 | 33.0000 |
|
| OCI-LY10 | R428 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | RAF265 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| OCI-LY10 | Rapamycin | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| OCI-LY10 | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | RG-108 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| OCI-LY10 | RITA | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | Ro-28-1675 | CTRP1 | 4.1667 | 533.3300 |
|
| OCI-LY10 | RO4929097 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | rosiglitazone | CTRP1 | 2.0833 | 266.6700 |
|
| OCI-LY10 | rotenone | CTRP1 | 0.0163 | 2.0833 |
|
| OCI-LY10 | RS-23597-190 | CTRP1 | 4.1667 | 533.3300 |
|
| OCI-LY10 | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | salermide | CTRP2 | 0.0120 | 400.0000 |
|
| OCI-LY10 | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| OCI-LY10 | Saracatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| OCI-LY10 | SB-225002 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| OCI-LY10 | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | SCH-529074 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | SCH-79797 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| OCI-LY10 | Selisistat | CTRP2,CTRP1 | 0.0024 | 80.0000 |
|
| OCI-LY10 | Selumetinib | CTRP2,CTRP1,CCLE | 0.0025 | 270.0000 |
|
| OCI-LY10 | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| OCI-LY10 | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| OCI-LY10 | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| OCI-LY10 | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| OCI-LY10 | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| OCI-LY10 | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| OCI-LY10 | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| OCI-LY10 | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Sepantronium bromide | CTRP2,CTRP1 | 0.0000 | 1.0417 |
|
| OCI-LY10 | Serdemetan | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | SID 26681509 | CTRP2,CTRP1 | 0.0090 | 300.0000 |
|
| OCI-LY10 | sildenafil | CTRP1 | 4.1667 | 533.3300 |
|
| OCI-LY10 | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | simvastatin | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| OCI-LY10 | SJ-172550 | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| OCI-LY10 | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | SKI-II | CTRP1 | 1.0417 | 133.3300 |
|
| OCI-LY10 | SN-38 | CTRP1 | 0.0090 | 1.1533 |
|
| OCI-LY10 | SNX-2112 | CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| OCI-LY10 | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| OCI-LY10 | Sorafenib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| OCI-LY10 | sotrastaurin | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | sparfosic acid | CTRP1 | 2.0833 | 266.6700 |
|
| OCI-LY10 | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | SR-II-138A | CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| OCI-LY10 | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | T-5345967 | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| OCI-LY10 | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | tacrolimus | CTRP2,CTRP1 | 0.0023 | 74.0000 |
|
| OCI-LY10 | tamatinib | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | Tamoxifen | CTRP2,CTRP1 | 0.0030 | 100.0000 |
|
| OCI-LY10 | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Tanespimycin | CTRP2,CTRP1,CCLE | 0.0010 | 33.0000 |
|
| OCI-LY10 | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| OCI-LY10 | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | Telomerase Inhibitor IX | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| OCI-LY10 | Temozolomide | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Teniposide | CTRP1 | 0.0326 | 4.1667 |
|
| OCI-LY10 | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | TGX-115 | CTRP1 | 4.1667 | 533.3300 |
|
| OCI-LY10 | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Thalidomide | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | tipifarnib-P1 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | tipifarnib-P2 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Tivozanib | CTRP2,CTRP1 | 0.0004 | 33.3330 |
|
| OCI-LY10 | TKI258 | CCLE | 0.0025 | 8.0000 |
|
| OCI-LY10 | Topotecan | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| OCI-LY10 | tosedostat | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| OCI-LY10 | Tozasertib | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Trametinib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Tretinoin | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| OCI-LY10 | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| OCI-LY10 | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| OCI-LY10 | triacsin C | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | triptolide | CTRP2,CTRP1 | 0.0000 | 0.3000 |
|
| OCI-LY10 | TTNBP | CTRP1 | 0.0260 | 3.3333 |
|
| OCI-LY10 | Tubastatin A | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | TW 37 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | tyrphostin AG-1478 | CTRP1 | 1.4787 | 189.2800 |
|
| OCI-LY10 | ubistatin B | CTRP1 | 4.1667 | 533.3300 |
|
| OCI-LY10 | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | UNC0638 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| OCI-LY10 | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | ursolic acid | CTRP1 | 1.8247 | 233.5600 |
|
| OCI-LY10 | VAF-347 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | valdecoxib | CTRP2,CTRP1 | 0.0180 | 600.0000 |
|
| OCI-LY10 | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | Venetoclax | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | VER-155008 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| OCI-LY10 | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| OCI-LY10 | Vismodegib | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | Vorinostat | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| OCI-LY10 | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | WT-161 | CTRP1 | 0.2604 | 33.3330 |
|
| OCI-LY10 | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | XAV939 | CTRP1 | 0.2891 | 37.0000 |
|
| OCI-LY10 | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
| OCI-LY10 | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| OCI-LY10 | ZD-6474 | CCLE | 0.0025 | 8.0000 |
|
| OCI-LY10 | zebularine | CTRP2,CTRP1 | 0.0180 | 592.0000 |
|
| OCI-LY10 | zileuton | CTRP1 | 4.1667 | 533.3300 |
|
| OCI-LY10 | ZM336372 | CTRP1 | 2.6747 | 342.3700 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC